This stock is a lesson in understanding why majority of investors loose money
Oct Nov 2013 PAB awarded Orphan Drug Status, Patents and plans to commence PATSM6 combination trial which realistically was at least 18 months off if not longer so early 2015 for the star of trials
Market and investors take the stock as high as 8c and give the stock a $45m Mkt Cap
Even when the stock fell back to 5c it was on the back of that rights issue and so the market cap was expected to be $50m
Anyone buying then bought the Boom And the hype
June 2015 PAB admits that the production of the drug for the trial has been a failure due to strict end points not being met despite trying over the last 7-8 months to rectify the issue. The reality is it will cost another $1m and time worst case to fix the issue with producing a drug that has been PATENTED and achieved ORPHAN DRUG DESIGNATION in U.S. and EU the worlds two largest drug markets.
Company has over $5m in the bank and is now trading around $5m Mkt Cap so zero value for assets and yet now it's a worthless failure
Anyone selling now is giving in to the Gloom and Doom
So here's the point PAB was a sell in Oct Nov 2013 not a buy
It's a buy now not a sell but the majority of investors will do the exact opposite which is why they say very few people make money trading specs
It's so simple Buy the Gloom and Doom Sell the Boom
Furniture I am convinced in the next 3months we will see this back over 1c and in the next 6months over 1.5c again like PXS just have to place your bets and hold your nerve and we'll reap the rewards
